Protocol β€Ί Origins Β· Last reviewed 2026-05-16

Origins: from Utrecht to VUmc Amsterdam

Summary

Services for children and young people with gender incongruence started in the Netherlands in 1987. According to the Cass Review the Dutch protocol was developed by Peggy Cohen-Kettenis, founder of the Utrecht clinic, and the use of puberty blockers for this purpose was first reported in a single case study of 1998 (Cohen-Kettenis and van Goozen), in which blockers were started at age 13 in a female-to-male transition (source). The protocol was elaborated in an article of 2006 (Delemarre-van de Waal and Cohen-Kettenis) and in the prospective study of de Vries et al. (2011) of the first 70 young people who received puberty blockers between 2000 and 2008 (source).

1. Prehistory: adult care

The gender identity clinic of the Vrije Universiteit Amsterdam has registered referrals of adults since 1972 (source), among others with endocrinologist Louis Gooren.1 According to the Cass Review, Cohen-Kettenis's initial clinical experience was in adult care (source).

2. The 1998 case

In 1998 Peggy Cohen-Kettenis and Stephanie van Goozen, then at the Utrecht University Hospital, published under the title "Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent" a postoperative follow-up case study of a female-to-male transsexual who was treated at age 13 with an LHRH agonist combined with psychotherapy and underwent sex reassignment at 18 (source) β€” see /studies/cohen-kettenis-1998/.2 According to the Cass Review the rationale was two-fold: to support the diagnostic procedure by buying time to think, and to improve the longer-term ability to pass in the preferred gender (source).

3. Formalisation 2006

The protocol was further elaborated in 2006 by Henriette Delemarre-van de Waal (paediatric endocrinologist, VUmc) and Cohen-Kettenis in European Journal of Endocrinology β€” see /studies/delemarre-2006/.3 According to the Cass Review, 54 patients were being treated by then (source).

4. Key figures

NameRolePeriod
Louis GoorenEndocrinologist, adult transgender care1972–2005
Peggy Cohen-KettenisClinical psychologist; according to Cass founder of the Utrecht clinicβ€”
Henriette Delemarre-van de WaalPaediatric endocrinologist1990–2010
Annelou de VriesChild psychiatrist, follow-up cohort2000–present
Thomas SteensmaDesistance researcher2005–present

5. Move to Amsterdam UMC

After the merger of AMC and VUmc into Amsterdam UMC (2018) the outpatient clinic continued under the name Knowledge and Care Centre for Gender Dysphoria, part of Amsterdam UMC, location VUmc. For current Dutch practice see /protocol/current-status-netherlands/.

Critical note

According to the Cass Review, the use of puberty blockers for this purpose was first reported in a single case study (1998) and then in the original Dutch cohort (2011) (source). Biggs (2023) concludes that the claims used to justify the intervention, that it is reversible and a tool for diagnosis, are increasingly implausible; the main evidence was a longitudinal study of 70 adolescents whose findings rested on a small number of observations and incommensurable measures of gender dysphoria, and a replication study in Britain found no improvement (source).4

See also

Footnotes

  1. Gooren LJG. Care of transsexual persons. N Engl J Med. 2011;364(13):1251–7.
  2. Cohen-Kettenis PT, van Goozen SHM. Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent. Eur Child Adolesc Psychiatry. 1998;7(4):246–8.
  3. Delemarre-van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents. Eur J Endocrinol. 2006;155(S1):S131–7.
  4. Biggs M. The Dutch Protocol for juvenile transsexuals: origins and evidence. J Sex Marital Ther. 2023;49(4):348–68.